Cardiotoxicity of Moderate Whole-Body Hyperthermia, Doxorubicin, and Combined Treatment in Rats

  • M. Birmelin
  • W. Hinkelbein
  • W. Oehlert
  • M. Wannenmacher
Conference paper
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 109)

Abstract

In clinical practice hyperthermia should enhance the cytotoxic effects of other cancer therapy modalities on tumors while not increasing side-effects on normal tissues. Interactions between hyperthermia and cytostatic drugs (Hahn 1982; Honess and Bleehen 1985; Neumann et al. 1985) on malignant cell lines or in experimental tumor models are well known, but only a few studies have been performed with defined treatment regimens in normal tissues (Overgaard and Suit 1979), especially in critical organs. In order to elucidate various toxic effects induced by combined therapy involving moderate whole-body hyperthermia (mWBH) and cytostatic drugs (thermochemotherapy, TCT) we examined specific side-effects of doxorubicin and/or mWBH.

Keywords

Toxicity Oncol Doxorubicin Cardiomyopathy Noma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bristow MR, Mason JW, Billingham ME, Daniels JR (1981) Dose effect and structure function relationships in doxorubicin cardiomyopathy. Am Heart J 102: 709–718PubMedCrossRefGoogle Scholar
  2. Doroshow JH, Locker GJ, Myers CE (1979) Experimental animal models of adriamycin cardiotoxicity. Cancer Treat Rep 63: 855–860PubMedGoogle Scholar
  3. Engelhardt R (1983) Clinical trials on thermo-chemotherapy (TCT), TCT in small cell carcinoma of the lung. Strahlentherapie 159: 371–372Google Scholar
  4. Hahn GM (1982) Thermal enhancement of the actions of anticancer agents. In: Hahn GM (ed) Hyperthermia and cancer. Plenum, New York, pp 55–86Google Scholar
  5. Honess DJ, Bleehen NM (1985) Potentiation of mephalan by systemic hyperthermia in mice: therapeutic gain for mouse lung microtumours. Int J Hyperthermia 1: 57–68PubMedCrossRefGoogle Scholar
  6. Neumann HA, Fiebig HH, Löhr GW, Engelhardt R (1985) Effects of cytostatic drugs and 40.5° C hyperthermia on human clonogenic tumor cells. Eur J Cancer Clin Oncol 21: 515–523PubMedCrossRefGoogle Scholar
  7. Overgaard J (1983) Histopathologic effects of hyperthermia. In: Storm FK (ed) Hyperthermia in cancer therapy. Hall, Boston, pp 163–164Google Scholar
  8. Overgaard J, Suit HD (1979) Time-temperature relationship in hyperthermic treatment of malignant and normal tissue in vivo. Cancer Res 39: 3248–3253PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • M. Birmelin
    • 1
  • W. Hinkelbein
    • 1
  • W. Oehlert
    • 1
  • M. Wannenmacher
    • 1
  1. 1.Abteilung für Innere Medizin IV, DialysestationMedizinische UniversitätsklinikFreiburgGermany

Personalised recommendations